SCHEMBL7088159

SCHEMBL7088159

c1ccc(-c2cccc(-c3ccc4cc[nH]c4c3)c2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.67
ADORA2A P29274 1/20 0.55
ADORA1 P30542 1/20 0.55
GHSR Q92847 3/20 0.54
FGFR1 P11362 1/20 0.49
AHR P35869 4/20 0.48
TRPA1 O75762 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
ITGB2 P05107 1/20 0.48
ICAM1 P05362 1/20 0.48
ITGAL P20701 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
ADK P55263 1/20 0.48
CMA1 P23946 1/20 0.47
TYR P14679 1/20 0.47
PIP4K2A P48426 1/20 0.47
PIP4K2B P78356 1/20 0.47
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL443799 0.96 NPC1 (0.71) NPC1ADORA2AADORA1GHSRFGFR1
SCHEMBL30253604 0.96 NPC1 (0.71) NPC1ADORA2AADORA1GHSRFGFR1
SCHEMBL7084471 0.82 NPC1 (0.58) NPC1ADORA2AADORA1GHSRAHR
SCHEMBL24601496 0.82 NPC1 (0.50) NPC1ADORA2AADORA1GHSRAHR
SCHEMBL7091322 0.82 NPC1 (0.54) NPC1ADORA2AADORA1GHSRAHR
SCHEMBL25811843 0.82 NPC1 (0.50) NPC1ADORA2AADORA1GHSRAHR
SCHEMBL5464492 0.81 NPC1 (0.49) NPC1ADORA2AADORA1GHSRAHR
SCHEMBL5664020 0.81 AHR (0.63) NPC1ADORA2AADORA1AHRCMA1
SCHEMBL7087919 0.81 AHR (0.63) NPC1ADORA2AADORA1GHSRAHR
SCHEMBL981855 0.81 ADORA2A (0.52) NPC1ADORA2AADORA1AHRCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203959-A1 Novel modulators of potassium channels 4SC AG (DE) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203959-A1 Novel modulators of potassium channels HCN3, KCNN3, KCNN1 NPC1 487/4885ADORA2A 883/4885ADORA1 347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.